rupintrivir and other clinical-stage product candidates. Most recently, Dr. Worland founded and led eFFECTOR Therapeutics, a clinical-stage biopharmaceutical company pioneering the development of ...
rupintrivir and other clinical-stage product candidates. Most recently, Dr. Worland founded and led eFFECTOR Therapeutics, a clinical-stage biopharmaceutical company pioneering the development of ...
Most of the antiviral agents that have been approved, and are currently used in the treatment of virus infections, are targeted at HIV, HBV, herpes simplex virus (HSV), varicella-zoster virus (VZV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback